| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 04/13/2011 | EP2308514A2 Conjugates for targeted drug delivery across the blood-brain barrier |
| 04/13/2011 | EP2308513A2 Fluorescent nanoparticles |
| 04/13/2011 | EP2308512A1 Water-containing composition |
| 04/13/2011 | EP2308511A1 Tablet quickly disintegrating in the oral cavity and method for producing the same |
| 04/13/2011 | EP2308510A1 Agent for regeneration and/or protection of nerves |
| 04/13/2011 | EP2308496A2 Formulation containing phosphate derivatives of electron transfer agents |
| 04/13/2011 | EP2308493A1 Ameliorating or therapeutic agent for dyslipidemia |
| 04/13/2011 | EP2308483A1 Process for production of spherical microparticles comprising tamsulosin hydrochloride |
| 04/13/2011 | EP2308479A2 Compounds and compositions for delivering active agents |
| 04/13/2011 | EP2308475A1 Matrix for sustained, invariant and independent release of active compounds |
| 04/13/2011 | EP2308474A1 Matrix for sustained, invariant and independent release of active compounds |
| 04/13/2011 | EP2308473A1 Pharmaceutical composition containing surface-coated microparticles |
| 04/13/2011 | EP2308469A1 Formulations for alteration of biophysical properties of mucosal lining |
| 04/13/2011 | EP2308466A1 Aqueous pharmaceutical compositions containing borate-polyol complexes |
| 04/13/2011 | EP2308456A1 Water-in-oil emulsions comprising vinyl polymers carrying ethylene oxide groups in side chains, compositions, and methods |
| 04/13/2011 | EP2307505A1 Emulsion composition, methods of softening fibrous structures using the same, and fibrous substrate treated therewith |
| 04/13/2011 | EP2307058A2 Glycerophospholipids for the improvement of cognitive functions |
| 04/13/2011 | EP2307057A1 Manufacturing method of collagen gel composition for bone regeneration |
| 04/13/2011 | EP2307056A2 Stabilized aqueous formulation containing paracetamol |
| 04/13/2011 | EP2307055A2 Method for treating atrophic age related macular degeneration |
| 04/13/2011 | EP2307054A2 Edible holographic silk products |
| 04/13/2011 | EP2307048A2 Hiv vaccine based on targeting maximized gag and nef to dendritic cells |
| 04/13/2011 | EP2307035A2 Treatment for epilepsy |
| 04/13/2011 | EP2307032A2 Novel conjugates of polymers having a therapeutically active agent and an angiogenesis targeting moiety attached thereto and uses thereof in the treatment of angiogenesis related diseases |
| 04/13/2011 | EP2307031A1 Film-forming liquid formulations for drug release to hair and scalp |
| 04/13/2011 | EP2307022A1 Enhanced nsaid formulations |
| 04/13/2011 | EP2306999A2 Compositions for treating rosacea |
| 04/13/2011 | EP2306993A1 Protamine/rna nanoparticles for immunostimulation |
| 04/13/2011 | EP2306992A2 Delivery particle |
| 04/13/2011 | EP2306979A1 Liposomes capable of effectively binding the beta amyloid peptide |
| 04/13/2011 | EP2306977A1 Method and composition for treating ocular hypertension and glaucoma |
| 04/13/2011 | EP2306976A2 Injectable taxane pharmaceutical composition |
| 04/13/2011 | EP2306975A2 Controlled-release otic structure modulating and innate immune system modulating compositions and methods for the treatment of otic disorders |
| 04/13/2011 | EP2306974A1 A topical composition comprising the isolated non-polar lipid fraction of lan0lin4 |
| 04/13/2011 | EP2306972A1 Acetic acid and a buffer |
| 04/13/2011 | EP2306971A1 Unit dosage of apadenoson |
| 04/13/2011 | EP2306929A1 Medical devices and methods for delivery of nucleic acids |
| 04/13/2011 | EP2068935B1 Polymer conjugates of box-a of hmgb1 and box-a variants of hmgb1 |
| 04/13/2011 | EP1883698B1 Monoclonal antibodies and single chain antibody fragments against cell-surface prostate specific membrane antigen |
| 04/13/2011 | EP1778251B1 Nucleoside phosphonate conjugates as anti hiv agents |
| 04/13/2011 | EP1759001B1 Bone delivery conjugates and method of using same to target proteins to bone |
| 04/13/2011 | EP1699847B1 Method for the preparation of medicinal compositions |
| 04/13/2011 | EP1636295B1 Drug delivery device comprising an active compound and method for releasing an active compound from a drug delivery device |
| 04/13/2011 | EP1438026B1 Taste masking spill-resistant formulation |
| 04/13/2011 | EP1345628B1 Conjugates of erythropoietin (epo) with polyethylene glycol (peg) |
| 04/13/2011 | EP1274473B2 Antimicrobial bioabsorbable materials |
| 04/13/2011 | EP1237584B1 Receptor binding conjugates |
| 04/13/2011 | EP1181044B1 IMMOBILIZED LACTOFERRIN ( i Im /i -LF) ANTIMICROBIAL AGENTS AND USES THEREOF |
| 04/13/2011 | CN1879888B Transdermal drug administration intensifier and its usage method |
| 04/13/2011 | CN1874774B Solid preparation comprising an insulin sensitizer, an insulin secretagogue and a polyoxyethylene sorbitan fatty acid ester |
| 04/13/2011 | CN1839806B Methods for in vivo delivery of biologics and compositions useful therefor |
| 04/13/2011 | CN1665488B Direct cellular energy delivery system |
| 04/13/2011 | CN102014967A Use of pyrene to carry peptides across the blood brain barrier |
| 04/13/2011 | CN102014966A Therapeutic use of new pharmaceutical preparations containing antitumoral drugs bound to hyaluronic acid in the treatment of neoplasias |
| 04/13/2011 | CN102014965A PEGylated recombinant human growth hormone compounds |
| 04/13/2011 | CN102014964A Compositions and methods for the treatment of tumor of hematopoietic origin |
| 04/13/2011 | CN102014963A Tooth movement activating compound |
| 04/13/2011 | CN102014962A Dissolvable nano web porous film and method of preparing the same |
| 04/13/2011 | CN102014961A Volatile anesthetic compositions comprising extractive solvents for regional anesthesia and/or pain relief |
| 04/13/2011 | CN102014957A Auris formulations for treating otic diseases and conditions |
| 04/13/2011 | CN102014955A Carbohydrate-containing pan cancer marker |
| 04/13/2011 | CN102014952A Vaccine compositions for the treatment of dengue fever and uses thereof |
| 04/13/2011 | CN102014951A Sustained release poloxamer containing pharmaceutical compositions |
| 04/13/2011 | CN102014935A Compositions and methods for using stromal cells to enhance treatment of central nervous system injuries |
| 04/13/2011 | CN102014909A Solid preparation for oral administration |
| 04/13/2011 | CN102014905A Donepezil-containing patch preparation and packaging thereof |
| 04/13/2011 | CN102014904A Liquid formulation for deferiprone with palatable taste |
| 04/13/2011 | CN102014901A Pharmaceutical composition |
| 04/13/2011 | CN102014883A Edible film-strips with modified release active ingredients |
| 04/13/2011 | CN102014882A Edible film-strips for immediate release of active ingredients |
| 04/13/2011 | CN102014881A Pharmaceutical preparation |
| 04/13/2011 | CN102014877A Pharmaceutical dosage form |
| 04/13/2011 | CN102014875A Formulation with reduced hygroscopicity |
| 04/13/2011 | CN102010527A Chitosan nano particle and preparation method thereof |
| 04/13/2011 | CN102010525A Method for preparing superparamagnetic micron starch |
| 04/13/2011 | CN102010513A Stable polysaccharide modified gelatin nano particle and preparation method and application thereof |
| 04/13/2011 | CN102010488A Thermo-sensitive and degradable micro hydrogel as well as preparation method and application thereof |
| 04/13/2011 | CN102010473A Recombinant oxyntomodulin (OXM) fusion protein, and preparation and application thereof |
| 04/13/2011 | CN102008926A Method for preparing starch microspheres |
| 04/13/2011 | CN102008739A Solid refreshment agent |
| 04/13/2011 | CN102008734A Inclusion compound of alpha crystal imatinib and preparation method thereof |
| 04/13/2011 | CN102008733A Anti-tumor controlled release nanocomposite and preparation method thereof |
| 04/13/2011 | CN102008732A Folate conjugated antibody medicament and preparation method and application thereof |
| 04/13/2011 | CN102008731A Preparation method of fluorocarbon nanometer medicine-carrying preparation using block copolymer as carrier |
| 04/13/2011 | CN102008730A Transdermal medicine composition and transdermal medicine kit |
| 04/13/2011 | CN102008729A Composition for external use |
| 04/13/2011 | CN102008728A Liquid depot formulations |
| 04/13/2011 | CN102008727A Injection-purpose medicine composition for improving stability of ligustrazine medicine injection formulation and preparation method of injection-purpose medicine composition |
| 04/13/2011 | CN102008719A Immunomicrosphere for overcoming B cell immunological tolerance and application thereof |
| 04/13/2011 | CN102008714A Ointment for promoting rapid healing of scabby chilblain |
| 04/13/2011 | CN102008713A Ciclosporin A proliposome, pharmaceutical composition and preparation method thereof |
| 04/13/2011 | CN102008611A External cream for treating summer-damp cold by using transdermal absorption technology |
| 04/13/2011 | CN102008585A Sihuang anti-dysentery effervescent particle and preparation method thereof |
| 04/13/2011 | CN102008556A Qiqing Baidu effervescent granule and preparation method thereof |
| 04/13/2011 | CN102008552A Daphniphyllum calycinum and knees herb dispersible tablet for gastrointestinal health and preparation method thereof |
| 04/13/2011 | CN102008546A External medical cream for pain and itching relieving and detumescence |
| 04/13/2011 | CN102008542A Compound neomycin sulfate soluble powder and production method thereof |
| 04/13/2011 | CN102008536A Tripterygium wilfordii hook extract cataplasm and preparation method thereof |
| 04/13/2011 | CN102008531A Fufukang gel and preparation method thereof |
| 04/13/2011 | CN102008525A Pellet of celery seed extract and preparation method thereof |